Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

Clinical trial NCT00514046 · COMPLETED

Trial details

NCT number: NCT00514046
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2B

Start date: 2007-07-20
Primary completion: 2019-12-10
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.